Key points: MRD negativity is a predictor for long-term progression-free and overall survival independent of the type and line of therapy. MRD negativity confers the greatest prognostic benefit when achieved in the frontline setting.
Home / Resource Library / Minimal residual disease is an independent predictor for 10-year survival in CLL